4,613 results match your criteria Intra-aortic Balloon Counterpulsation

Veno-Arterial Extracorporeal Membrane Oxygenation in Elective High-Risk Percutaneous Coronary Interventions.

Front Med (Lausanne) 2022 26;9:913403. Epub 2022 May 26.

The First School of Clinical Medicine of Lanzhou University, Lanzhou, China.

Background: The safety and feasibility of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) as mechanical circulatory support in high-risk percutaneous coronary intervention (HR-PCI) remain unclear.

Methods: This retrospective study included patients with complex and high-risk coronary artery disease who underwent elective PCI with VA-ECMO support pre-operatively during March 2019-December 2020. Rates of VA-ECMO-related complications, complications during PCI, death, myocardial infarction, and stroke during hospitalisation and 1-year post-operatively were analysed. Read More

View Article and Full-Text PDF

Gangrene of the Foot After Coronary Artery Bypass Graft Surgery.

Perm J 2022 Apr 5;26(1):143-147. Epub 2022 Apr 5.

Department of Internal Medicine, Kaiser Permanente, Sacramento, CA, USA.

Coronary artery bypass grafting (CABG) is the most common surgery performed by cardiothoracic surgeons worldwide. Risks of CABG include neurological outcomes, deep vein thrombosis, renal or gastrointestinal injury, and death. Perioperatively, some patients may need intra-aortic balloon pump (IABP) use to help assist with cardiac function. Read More

View Article and Full-Text PDF

Nephrology Considerations in the Management of Durable and Temporary Mechanical Circulatory Support.

Kidney360 2022 03 14;3(3):569-579. Epub 2022 Jan 14.

Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas.

Durable and temporary mechanical circulatory support (MCS) use is growing for a range of cardiovascular indications. Kidney dysfunction is common in people evaluated for or receiving durable or temporary MCS and portends worse outcomes. This kidney dysfunction can be due to preexisting kidney chronic kidney disease (CKD), acute kidney injury (AKI) related to acute cardiovascular disease necessitating MCS, AKI due to cardiac procedures, and acute and chronic MCS effects and complications. Read More

View Article and Full-Text PDF

Prophylactic Mechanical Circulatory Support Use in Elective Percutaneous Coronary Intervention for Patients With Stable Coronary Artery Disease.

Circ Cardiovasc Interv 2022 May 17;15(5):e011534. Epub 2022 May 17.

Duke Clinical Research Institute, Duke University Medical Center, Durham, NC (M.Z., G.M.G., P.Z., D.M.W., S.V.R., T.Y.W.).

Background: Mechanical circulatory support (MCS) devices can be used in high-risk percutaneous coronary intervention (PCI). Our objective was to describe trends and outcomes of prophylactic MCS use in elective PCI for patients with stable coronary artery disease in the American College of Cardiology National Cardiovascular Data Registry's CathPCI registry.

Methods: Among 2 108 715 consecutive patients with stable coronary artery disease undergoing elective PCI in the CathPCI registry between 2009 and 2018, we examined patterns of prophylactic use of MCS. Read More

View Article and Full-Text PDF

Mechanical Circulatory Support Options in Patients With Aortic Valve Pathology.

J Cardiothorac Vasc Anesth 2022 Aug 14;36(8 Pt B):3318-3326. Epub 2022 Apr 14.

Department of Anesthesiology and Perioperative Medicine, TuftsMedical Center, 800 Washington Street, Ziskind Building 6th Floor, Boston, MA02111. Electronic address:

Mechanical circulatory support (MCS) is used in cardiogenic shock for periprocedural hemodynamic stability in high-risk patients and to support patients with symptomatic coronary artery disease. Depending on the MCS type, oxygenation and ventilation, in addition to increasing blood pressure by augmenting blood flow, can be achieved. MCS typically follows a failure of less invasive maneuvers or intolerance to them, such as significant ventricular arrhythmia burden from inotropic support. Read More

View Article and Full-Text PDF

Predicting outcomes of mesenteric ischemia postcardiac surgery: A systematic review.

J Card Surg 2022 Jul 30;37(7):2025-2039. Epub 2022 Apr 30.

Department of Cardiothoracic Surgery, Liverpool Heart and Chest Hospital, Liverpool, UK.

Objective: This systematic review aims to identify predictors of outcomes of mesenteric ischemia in patients following cardiac surgery.

Methods: A comprehensive literature search was done on EMBASE, PubMed, Ovid MEDLINE, and SCOPUS using keywords relating to bowel ischemia and cardiac surgery. Database search results were screened by at least two authors and 32 articles were selected for inclusion in this review. Read More

View Article and Full-Text PDF

Gender Differences in the Outcomes of Cardiogenic Shock Requiring Percutaneous Mechanical Circulatory Support.

Am J Cardiol 2022 Jul 24;174:20-26. Epub 2022 Apr 24.

University of Texas Health Science Center at Houston, Department of Medicine, Division of Cardiology, Houston, TX.. Electronic address:

There is evidence for the lower use of percutaneous mechanical circulatory support (pMCS) in women. We aimed to determine (1) whether gender differences exist regarding in-hospital mortality, hospital course, and procedures; (2) whether socio-demographic and treatment-related factors were associated with these differences. Using the National Inpatient Sample, we collected the International Classification of Diseases, Ninth Revision, Clinical Modification codes for cardiogenic shock (CS) because of acute myocardial infarction AMI or acutely decompensated advanced heart failure and included intra-aortic balloon pump, Impella or Tandem Heart percutaneous ventricular assist devices (pVADs), extracorporeal membrane oxygenation. Read More

View Article and Full-Text PDF

Bedside intra-aortic balloon pump insertion in cardiac intensive care unit: A single-center experience.

Catheter Cardiovasc Interv 2022 Jun 14;99(7):1976-1983. Epub 2022 Apr 14.

Cardiac Intensive Care Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Background: In contemporary Cardiac Intensive Care Unit (CICU), bedside intra-aortic balloon pump (IABP) insertion under echocardiographic guidance may be an attractive option for selected patients with cardiogenic shock (CS). Currently available data on this approach are limited.

Aim: This study aimed to assess the feasibility and safety of bedside IABP insertion, as compared to fluoroscopic-guided insertion in the Catheterization Laboratory (CathLab), and to describe the clinical features of patients receiving bedside IABP insertion using a standardized technique in real-world CICU practice. Read More

View Article and Full-Text PDF

The Use of Mechanical Circulatory Assist Devices for ACS Patients with Cardiogenic Shock and High-Risk PCI.

Curr Cardiol Rep 2022 Jun 11;24(6):699-709. Epub 2022 Apr 11.

Baylor College of Medicine, 7200 Cambridge St, Ste 6C, Houston, TX, 77030, USA.

Purpose Of Review: There has been a significant expansion of the use of mechanical circulatory support (MCS) devices for patient with acute coronary syndromes (ACS) with cardiogenic shock (CS) and in patients undergoing high-risk percutaneous interventions (PCI). The purpose of this review is to provide an overview of the indications and outcomes of these devices in high-risk cardiac patients.

Recent Findings: Early revascularization of the culprit-lesion is the immediate goal in ACS patients with CS and the use of pulmonary artery catheters has been associated with improved outcomes in patients with cardiogenic shock. Read More

View Article and Full-Text PDF

Seronegative immune-mediated necrotising myopathy complicated by fulminant myocarditis resulting in cardiogenic shock and cardiac arrest.

BMJ Case Rep 2022 Apr 4;15(4). Epub 2022 Apr 4.

Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, Texas, USA.

A woman in her late 30s recently diagnosed with viral myopericarditis presented with 1 month of worsening fatigue, diffuse myalgias and chest pain radiating to her back. While undergoing work-up for chest wall myositis, she rapidly decompensated, developing heart failure and acute hypoxaemic respiratory failure. Her clinical course was complicated by cardiac arrest and severe cardiogenic shock requiring intra-aortic balloon pump support. Read More

View Article and Full-Text PDF

Impact of Timing of Impella Support in Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock.

Cardiovasc Revasc Med 2022 Jun 29;39:36-37. Epub 2022 Mar 29.

Section of Cardiothoracic Surgery, St. Francis Medical Center, Monroe, LA, United States of America.

View Article and Full-Text PDF

Outcomes of Venoarterial Extracorporeal Membrane Oxygenation Plus Intra-Aortic Balloon Pumping for Treatment of Acute Myocardial Infarction Complicated by Cardiogenic Shock.

J Am Heart Assoc 2022 04 4;11(7):e023713. Epub 2022 Apr 4.

Department of Cardiology Kawasaki Medical School Kurashiki Okayama Japan.

Background Clinical outcomes of acute myocardial infarction complicated by cardiogenic shock remain poor with high in-hospital mortality. Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) has been widely used for patients with acute myocardial infarction complicated by cardiogenic shock refractory to conservative therapy, which is likely fatal without mechanical circulatory support. However, whether additional intra-aortic balloon pumping (IABP) use during VA-ECMO support improves clinical outcomes remains controversial. Read More

View Article and Full-Text PDF

Intra-Aortic Balloon Pump for Left Ventricular Unloading in Veno-Arterial Extracorporeal Membrane Oxygenation: The Last Remaining Indication in Cardiogenic Shock.

J Am Heart Assoc 2022 04 4;11(7):e025274. Epub 2022 Apr 4.

Division of Cardiovascular Medicine Department of Medicine Wake Forest University School of Medicine Winston-Salem NC.

View Article and Full-Text PDF

Mechanical Left Ventricular Unloading in Patients Undergoing Venoarterial Extracorporeal Membrane Oxygenation.

J Am Coll Cardiol 2022 04;79(13):1239-1250

Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

Background: Venoarterial extracorporeal membrane oxygenation (VA-ECMO) increases left ventricular (LV) afterload, potentially provoking LV distention and impairing recovery. LV mechanical unloading (MU) with intra-aortic balloon pump (IABP) or percutaneous ventricular assist device (pVAD) can prevent LV distension, potentially at the risk of more complications, and net clinical benefit remains uncertain.

Objectives: This study aims to determine the association between MU and outcomes for patients undergoing VA-ECMO. Read More

View Article and Full-Text PDF

Postcardiotomy Venoarterial Extracorporeal Membrane Oxygenation With and Without Intra-Aortic Balloon Pump.

J Cardiothorac Vasc Anesth 2022 Aug 11;36(8 Pt B):2876-2883. Epub 2022 Feb 11.

Department of Cardiothoracic Surgery, Skane University Hospital and Lund University, Lund, Sweden. Electronic address:

Objectives: To compare the outcomes of patients with postcardiotomy shock treated with venoarterial extracorporeal membrane oxygenation (VA-ECMO) only compared with VA-ECMO and intra-aortic balloon pump (IABP).

Design: A retrospective multicenter registry study.

Setting: At 19 cardiac surgery units. Read More

View Article and Full-Text PDF

Perioperative incidence of ECMO and IABP on 5901 mitral valve surgery procedures.

J Cardiothorac Surg 2022 Mar 17;17(1):38. Epub 2022 Mar 17.

Department of Cardiac Surgery, Perfusion Service, Anthea Hospital, GVM Care and Research, Via Camillo Rosalba 35/37, 70124, Bari, Italy.

Background: Report the incidence and results of peri-operative extracorporeal membrane oxygenation (ECMO) and intra-aortic balloon pump (IABP) of patients undergoing mitral valve surgery (MVS) through right mini-thoracotomy (RT) and conventional full sternotomy (FS) for a period of 6 years from eleven tertiary Cardiac Surgery Institutes of GVM Care & Research Italia.

Methods: From January 2016 to November 2021, a total of 5901 consecutive patients underwent MVS through RT and FS. The primary outcome of the study was the mortality and incidence of low cardiac output syndrome (LCOS) treated with intra-aortic balloon pump (IABP) with or without inotropic support and the incidence of Postcardiotomy Cardiogenic Shock (PCS) treated with Veno-arterial (VA) Extracorporeal Membrane Oxygenation (ECMO) on patients undergoing mitral valve surgery (MVS) through right mini-thoracotomy (RT) versus conventional full sternotomy (FS). Read More

View Article and Full-Text PDF

Benefit of veno-arterial extracorporeal membrane oxygenation combined with Impella (ECpella) therapy in acute coronary syndrome with cardiogenic shock.

J Cardiol 2022 08 12;80(2):116-124. Epub 2022 Mar 12.

Department of Cardiac and Vascular Surgery, Dokkyo Medical University School of Medicine, Mibu, Japan.

Background: Patients with acute coronary syndrome complicated with cardiogenic shock (ACS-CS) frequently require mechanical circulatory support. In addition to veno-arterial extracorporeal membrane oxygenation (VA-ECMO), use of the Impella® (ECpella) (Abiomed Inc., Danvers, MA, USA) heart pump may improve the prognosis of such patients. Read More

View Article and Full-Text PDF

Cerebral flow variation at different intra-aortic balloon settings in cardiogenic shock.

Eur Heart J Cardiovasc Imaging 2022 Jun;23(6):e270

Department of Anesthesia, Intensive Care and Pain Therapy, Fondazione Policlinico San Matteo Hospital Viale Golgi, 19 - 27100 - Pavia, Italy.

View Article and Full-Text PDF

Antithrombotic management for Impella temporary ventricular assist devices: An analysis of an academic health-system experience.

Int J Artif Organs 2022 Jun 13;45(6):550-559. Epub 2022 Mar 13.

New York University Langone Health, New York, NY, USA.

The use of acute mechanical circulatory support (MCS) has increased over the last decade. For patients with left-ventricular failure, an Impella (Abiomed, Danvers, MA) may be used to improve cardiac output. The purpose of this study is to describe Impella anticoagulation patterns and evaluate the safety and effectiveness of our protocol. Read More

View Article and Full-Text PDF

Rates and impact of vascular complications in mechanical circulatory support.

Catheter Cardiovasc Interv 2022 04 9;99(5):1702-1711. Epub 2022 Mar 9.

Division of Cardiovascular Medicine, Henry Ford Hospital, Detroit, Michigan, USA.

Background: Mechanical circulatory support (MCS) devices are increasingly used for hemodynamic support in cardiogenic shock or high-risk percutaneous coronary interventions. Vascular complications remain a major source of morbidity and mortality despite technological advances with percutaneous techniques. Little is known about the rates and predictors of vascular complications with large-bore access MCS in the contemporary era. Read More

View Article and Full-Text PDF

Associated factors and clinical outcomes in mechanical circulatory support use in patients undergoing high risk on-pump cardiac surgery: Insights from the LEVO-CTS trial.

Am Heart J 2022 06 7;248:35-41. Epub 2022 Mar 7.

Department of Critical Care Medicine, University of Alberta, Edmonton, Alberta, Canada; Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada; Division of Cardiology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada. Electronic address:

Background: We describe variables and outcomes associated with peri-operative mechanical circulatory support (MCS) utilization among patients enrolled in the Levosimendan in patients with Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass (LEVO-CTS) trial.

Methods: In the LEVO-CTS trial, MCS utilization (defined as intra-aortic balloon pump, extracorporeal membrane oxygenation, or surgical ventricular assist device) within 5 days of surgery was examined. The association between MCS use and outcomes including 90-day mortality, 30-day renal-replacement therapy, and hospital and critical stay length of stay were determined. Read More

View Article and Full-Text PDF

Recovery With Temporary Mechanical Circulatory Support While Waitlisted for Heart Transplantation.

J Am Coll Cardiol 2022 03;79(9):900-913

Division of Cardiovascular Medicine, Department of Internal Medicine, University of Utah and Salt Lake Veterans Affairs Medical Center, Salt Lake City, Utah, USA.

Background: The 2018 U.S. heart allocation system offers an accelerated pathway for heart transplantation to the most urgent patients. Read More

View Article and Full-Text PDF

Is cardiac surgery backup required for left main stenting?

Catheter Cardiovasc Interv 2022 02;99(3):607-608

Mount Sinai School of Medicine-Cardiovascular Institute, New York, New York, USA.

View Article and Full-Text PDF
February 2022

Mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock.

Rev Cardiovasc Med 2022 Feb;23(2):71

Department of Cardiology, Freeman Hospital, NE7 7DN Newcastle upon Tyne, UK.

Patients with acute myocardial infarction (MI) complicated by cardiogenic shock (CS) have poor prognosis. Over the last two decades, there has been some improvement in mortality rates associated with CS. Initial measures to stabilise patients should follow a shock protocol, including therapies such as volume expansion, inotropes/vasopressors, and early coronary revascularisation. Read More

View Article and Full-Text PDF
February 2022

Use of Impella in Patients Listed for Heart Transplantation.

ASAIO J 2022 06 16;68(6):786-790. Epub 2022 Feb 16.

From the Department of Cardiovascular and Thoracic Surgery, University of Louisville, Louisville, Kentucky.

The new United Network for Organ Sharing (UNOS) policy has resulted in a significantly higher number of temporary mechanical circulatory support device usage such as extracorporeal membrane oxygenation, Impella, and intra-aortic balloon pump due to provision of higher priority with their use while on the waiting list. We aimed to identify Impella use in patients awaiting heart transplantation and temporal changes in its usage. The UNOS database was queried between years 2015 and 2019 for patients aged greater than or equal to 18 years, listed to undergo heart transplantation. Read More

View Article and Full-Text PDF

Timing of mechanical circulatory support during primary angioplasty in acute myocardial infarction and cardiogenic shock: Systematic review and meta-analysis.

Catheter Cardiovasc Interv 2022 03 19;99(4):998-1005. Epub 2022 Feb 19.

Department of Innovative Technologies in Medicine & Odontology, Institute of Cardiology, "G. d'Annunzio" University, Chieti, Italy.

Objectives: We aim to define whether the timing of microaxial left ventricular assist device (IMLVAD) implantation might impact on mortality in acute myocardial infarction (AMI) cardiogenic shock (CS) patients who underwent primary percutaneous coronary intervention (PPCI).

Background: Despite the widespread use of PPCI, mortality in patients with AMI and CS remains high. Mechanical circulatory support is a promising bridge to recovery strategy, but evidence on its benefit is still inconclusive and the optimal timing of its utilization remains poorly explored. Read More

View Article and Full-Text PDF

Mortality in cardiogenic shock patients receiving mechanical circulatory support: a network meta-analysis.

BMC Cardiovasc Disord 2022 02 13;22(1):48. Epub 2022 Feb 13.

Department of Emergency and Chest Pain Center, Qilu Hospital, Cheeloo College of Medicine, Shandong University, NO. 107, Jinan, 250012, Shandong, China.

Objective: Mechanical circulatory support (MCS) devices are widely used for cardiogenic shock (CS). This network meta-analysis aims to evaluate which MCS strategy offers advantages.

Methods: A systemic search of PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials was performed. Read More

View Article and Full-Text PDF
February 2022

Trials, Tribunals, and Opportunities in Cardiogenic Shock Research.

JACC Cardiovasc Interv 2022 02;15(3):305-307

Section of Cardiovascular Medicine, Department of Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA. Electronic address:

View Article and Full-Text PDF
February 2022